According to the 2016 WHO Classification of Tumors of the CNS, AT/RT is defined as having specific genetic alterations in the INI1/SMARCB1/hSNF5, or rarely, in the SMARCA4/BRG1 genes (3). This evidence concerns the gene SMARCB1 and central nervous system neoplasm.